Seeing Is Believing
Currently out of the existing stock ratings of Madison El-Saadi, 30 are a BUY (96.77%), 1 are a HOLD (3.23%).
Analyst Madison El-Saadi, currently employed at B. RILEY, carries an average stock price target met ratio of 27.08% that have a potential upside of 37.04% achieved within 94 days.
Madison El-Saadi’s has documented 59 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CAPR, Capricor Therapeutics at 14-Sep-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 9/19/2024. The price target of $11 was fulfilled within 27 days with a profit of $5.06 (85.19%) receiving and performance score of 31.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Jan-2024
$295
$137.86 (87.73%)
$297
12 days ago
(08-Oct-2026)
18/22 (81.82%)
$124.92 (73.45%)
246
Buy Since 12-Dec-2023
$267
$109.86 (69.91%)
$176
21 days ago
(29-Sep-2026)
5/6 (83.33%)
$80.86 (43.44%)
319
Hold Since 30-Apr-2026
$247
$89.86 (57.18%)
$251
25 days ago
(25-Sep-2026)
8/10 (80%)
$51.91 (26.61%)
152
Buy Since 16-Jan-2024
$258
$100.86 (64.18%)
$258
1 months 2 days ago
(18-Sep-2026)
10/12 (83.33%)
$50.22 (24.17%)
171
Buy Since 07-Jun-2018
$290
$132.86 (84.55%)
$290
1 months 19 days ago
(31-Aug-2026)
45/52 (86.54%)
$91.48 (46.08%)
739
Which stock is Madison El-Saadi most bullish on?
Which stock is Madison El-Saadi most reserved on?
What Year was the first public recommendation made by Madison El-Saadi?